![North American Leaders Commit to Better Pandemic Preparedness](https://www.g2intelligence.com/wp-content/uploads/2023/01/Jan18-2023.News_.NAPAPI-Update-Plan-iStock-1800x1250-1-1080x675.jpg)
North American Leaders Commit to Better Pandemic Preparedness
The recent Declaration of North America makes updating the current North American Plan for Animal and Pandemic Influenza a priority.
The recent Declaration of North America makes updating the current North American Plan for Animal and Pandemic Influenza a priority.
Dispute resolution mechanism is being overwhelmed by unexpected case volume and complexity.
According to a recent CMS report, the sheer volume of out-of-network payment disputes is overwhelming the system.
While most recent cases were the usual FCA and kickback-related issues, one involved the mischarging of federal grants by two biotech companies and their co-founder.
DNA sequencing technologies may revolutionize the early detection and prevention of the disease.
Though the federal spending bill passed at the end of December offers another year’s reprieve from PAMA price cuts, SALSA was not included.
Merger and acquisition deal volume and value were down last year, but deal impact was not.
Deals involving the development and commercialization of new cancer diagnostics and treatments were the most common in December.
Here are what G2 Intelligence considers to be the 10 most significant FDA lab testing clearances of 2022, in rough chronological order.
Here’s an approach to ensure your lab patients have the most positive financial experience possible.